Retraction Note: Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis
Arthritis Research & Therapy volume 24, Article number: 272 (2022)
Retraction Note: Arthritis Res Ther 15, R120 (2013)
The Editors in Chief have retracted this article. After publication, Fig 2 was corrected because images in it had been mislabelled . However, new concerns emerged regarding the following:
Partial image overlap in Fig 3A and C;
Concerns about band similarity within Western blots in Figs 5A,B and 6A,B;
The actin bands in 5B appear very similar to the ones published earlier in Fig. 5B in  by the same author group.
The authors were unable to produce raw data on request. The Editors have lost confidence in the integrity of the data in this article. None of the authors agree to this retraction.
Bagnato G, Bitto A, Irrera N, et al. Erratum to: Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis. Arthritis Res Ther. 2014;16:406. https://doi.org/10.1186/ar4534.
Bagnato G, Bitto A, Pizzino G, et al. Simvastatin attenuates the development of pulmonary and cutaneous fibrosis in a murine model of systemic sclerosis. Rheumatology. 2013;52(8):1377–86. https://doi.org/10.1093/rheumatology/ket144.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Bagnato, G., Bitto, A., Irrera, N. et al. Retraction Note: Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis. Arthritis Res Ther 24, 272 (2022). https://doi.org/10.1186/s13075-022-02973-w